← Back to Search

Neuromodulation Device

Wearable Bladder Neuromodulation Device for Overactive Bladder (REDUCEOAB Trial)

N/A
Waitlist Available
Research Sponsored by Avation Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing and capable of giving informed consent
Female Subjects of child-bearing potential must have a negative urine dip stick pregnancy test at baseline
Timeline
Screening 3 weeks
Treatment Varies
Follow Up length of study, on average 24 months
Awards & highlights

REDUCEOAB Trial Summary

This trial is testing a new, self-adjusting device to treat OAB (overactive bladder) compared to a sham device. The study will see if the new device is safe and effective.

Who is the study for?
Adults diagnosed with Overactive Bladder (OAB) for at least 3 months, experiencing frequent urination or incontinence. Participants must be stable on current medications affecting OAB and not pregnant. Excluded are those with neurogenic bladder causes, failed third-line treatments within 2 years, stress-predominant mixed urinary incontinence, polyuria, pacemaker/defibrillator users, other clinical study participants during this trial's term.Check my eligibility
What is being tested?
The trial is testing a new wearable device called the Avation System that doesn't require surgery against a Sham System to see if it helps adults with OAB. It's a controlled study where some people will get the real treatment and others won't but won't know which one they're getting.See study design
What are the potential side effects?
Potential side effects aren't specified here but could include skin irritation from the wearable device or abnormal sensations due to neuromodulation therapy.

REDUCEOAB Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing and able to agree to participate in the study.
Select...
I am a woman who can have children and my pregnancy test is negative.
Select...
I have had overactive bladder symptoms for at least 3 months.
Select...
My medication doses for OAB have been stable for at least 4 weeks.
Select...
I am 18 years old or older.

REDUCEOAB Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~length of study, on average 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and length of study, on average 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The proportion of Subjects with a successful response
Secondary outcome measures
Quality of Life Endpoints: Questionnaires
Other outcome measures
Open-Label Phase Endpoints

REDUCEOAB Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Experimental ArmActive Control1 Intervention
Avation System
Group II: Control ArmPlacebo Group1 Intervention
Sham Avation System

Find a Location

Who is running the clinical trial?

Avation Medical, Inc.Lead Sponsor
1 Previous Clinical Trials
5,000 Total Patients Enrolled

Media Library

Avation System (Neuromodulation Device) Clinical Trial Eligibility Overview. Trial Name: NCT05381116 — N/A
Overactive Bladder Research Study Groups: Experimental Arm, Control Arm
Overactive Bladder Clinical Trial 2023: Avation System Highlights & Side Effects. Trial Name: NCT05381116 — N/A
Avation System (Neuromodulation Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05381116 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of participants engaged in this experiment?

"Affirmative. Details found on clinicaltrials.gov corroborate that this medical trial, first published in April 2022, is actively seeking volunteers. The research team needs to recruit 150 people from a single health centre."

Answered by AI

Are there still openings for study participants?

"Affirmative. Clinicaltrials.gov details that this medical trial is currently looking for volunteers, with the first listing going up on April 14th 2022 and being updated most recently on May 16th 2022. 150 patients need to be recruited from 1 location."

Answered by AI

Who else is applying?

What site did they apply to?
Ochsner Medical Center
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I'm willing to try most anything to help my issues, it seems the older I get the more issues I have. I also like helping advance medical science.
PatientReceived 2+ prior treatments
~42 spots leftby Apr 2025